BRIEF-Anixa Biosciences Enters Letter of Intent with VERDI Solutions to Develop Artificial Intelligence-Guided Personalized and Off-the-Shelf Cancer Vaccines

Reuters
25 Mar
BRIEF-<a href="https://laohu8.com/S/ANIX">Anixa Biosciences</a> Enters Letter of Intent with VERDI Solutions to Develop Artificial Intelligence-Guided Personalized and Off-the-Shelf Cancer Vaccines

March 25 (Reuters) - Anixa Biosciences Inc ANIX.O:

  • ANIXA BIOSCIENCES ENTERS LETTER OF INTENT WITH VERDI SOLUTIONS TO DEVELOP ARTIFICIAL INTELLIGENCE-GUIDED PERSONALIZED AND OFF-THE-SHELF CANCER VACCINES

Source text: ID:nPnbwh3cRa

Further company coverage: ANIX.O

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10